{
  "_id": "c76ce467c069ca89d005e572ce579e0eaed932255ab4e0f879f28883ac5be7f7",
  "feed": "wall-street-journal",
  "title": "Merck Pushes Forward With Potential Deal for Seagen; Talks have picked up pace and the two companies are scheduled to meet this week",
  "text": "<p>It couldn't be learned whether Merck has already submitted a formal offer for the Washington State company. Other suitors were eyeing Seagen, people familiar with the matter have said, but none has surfaced yet.</p><p>If there is a deal, it would be significant, given that Seagen's market value is well over $30 billion. The shares have risen sharply since the Journal report.</p><p>There is no guarantee the companies will reach a deal or that regulators would bless it if they do. Among the factors giving Merck pause was the potential for a heightened risk of regulatory scrutiny, the Journal reported.</p><p>Merck Pushes Forward With Potential Deal for Seagen</p>",
  "published": "2022-06-23T23:25:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "nexusId": "10042334",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 31,
          "end": 36
        },
        {
          "start": 0,
          "end": 5
        },
        {
          "start": 595,
          "end": 600
        },
        {
          "start": 497,
          "end": 502
        }
      ]
    }
  ]
}